<?xml version="1.0" encoding="UTF-8"?>
<p id="par0345">A simple point-of-care device was developed to detect IgM and IgG antibodies against the SARS-CoV-2 virus in blood samples within 15–20 min. This provides the possibility to identify a more significant number of infected patients, mainly, asymptomatic carriers to prevent virus spread.</p>
